Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Adenocarcinoma of Lung"" wg kryterium: Temat


Tytuł :
Emergency rigid bronchoscopy and immunotherapy: successful combination in dramatic respiratory debut of pulmonary adenocarcinoma.
Autorzy :
Guarino C; Unit of Bronchoscopy, Monaldi Hospital-A.O. Dei Colli of Naples, Napoli, Italy.
Cesaro C; Unit of Bronchoscopy, Monaldi Hospital-A.O. Dei Colli of Naples, Napoli, Italy.
La Cerra G; Unit of Bronchoscopy, Monaldi Hospital-A.O. Dei Colli of Naples, Napoli, Italy.
Lucci R; Unit of Pathological Anatomy, Monaldi Hospital-A.O. Dei Colli of Naples, Napoli, Italy.
Cesaro F; Unit of Emergency Medicine and Surgery and First Aid, C.T.O. Hospital, Napoli, Italy.
Zamparelli E; Unit of Anesthesia and Resuscitation, Monaldi Hospital-A.O. Dei Colli of Naples, Napoli, Italy.
Pokaż więcej
Źródło :
Tumori [Tumori] 2021 Dec; Vol. 107 (6), pp. NP91-NP93. Date of Electronic Publication: 2021 Jun 17.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Bronchoscopy*/methods
Emergency Medical Services*
Immunotherapy*/methods
Adenocarcinoma of Lung/*diagnosis
Adenocarcinoma of Lung/*drug therapy
Adenocarcinoma of Lung/complications ; Adenocarcinoma of Lung/etiology ; Airway Obstruction/diagnosis ; Airway Obstruction/etiology ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/adverse effects ; Antineoplastic Agents, Immunological/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Biopsy ; Disease Management ; Female ; Humans ; Middle Aged ; Molecular Targeted Therapy ; Symptom Assessment ; Tomography, X-Ray Computed ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Radiologic Features of Resected Lung Adenocarcinoma With Epithelial-Mesenchymal Transition.
Autorzy :
Matsubara T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Tagawa T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan. Electronic address: .
Toyokawa G; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan; Department of Thoracic Surgery, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Chuo-ku, Fukuoka, Japan.
Kamitani T; Department of Clinical Radiology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Takada K; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Oba T; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Osoegawa A; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Mori M; Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka, Japan.
Pokaż więcej
Źródło :
The Annals of thoracic surgery [Ann Thorac Surg] 2021 Nov; Vol. 112 (5), pp. 1647-1655. Date of Electronic Publication: 2020 Nov 26.
Typ publikacji :
Journal Article
MeSH Terms :
Epithelial-Mesenchymal Transition*
Tomography, X-Ray Computed*
Adenocarcinoma of Lung/*diagnostic imaging
Adenocarcinoma of Lung/*pathology
Lung Neoplasms/*diagnostic imaging
Lung Neoplasms/*pathology
Adenocarcinoma of Lung/classification ; Adenocarcinoma of Lung/surgery ; Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Lung Neoplasms/classification ; Lung Neoplasms/surgery ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Zinc moderates circular RNA CircFOXP1 expression in order to regulate ferroptosis during lung adenocarcinoma.
Autorzy :
Li H; Department of Geriatrics, Xianyang Central Hospital, Xianyang, 712000, China.
Liu L; Department of Geriatrics, Xianyang Central Hospital, Xianyang, 712000, China. Electronic address: .
Pokaż więcej
Źródło :
Chemico-biological interactions [Chem Biol Interact] 2022 Jan 25; Vol. 352, pp. 109760. Date of Electronic Publication: 2021 Dec 16.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung/*drug therapy
Adenocarcinoma of Lung/*genetics
Ferroptosis/*drug effects
Forkhead Transcription Factors/*genetics
Lung Neoplasms/*drug therapy
Lung Neoplasms/*genetics
RNA, Circular/*genetics
Repressor Proteins/*genetics
Zinc/*administration & dosage
Adenocarcinoma of Lung/pathology ; Amino Acid Transport System y+/genetics ; Animals ; Cell Line, Tumor ; Cell Movement/genetics ; Cell Proliferation/genetics ; Epithelial-Mesenchymal Transition/genetics ; Female ; Ferroptosis/genetics ; Forkhead Transcription Factors/antagonists & inhibitors ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Lung Neoplasms/pathology ; Male ; Mice ; Mice, Nude ; Mice, SCID ; Middle Aged ; Prognosis ; RNA, Circular/metabolism ; Rats ; Repressor Proteins/antagonists & inhibitors
Czasopismo naukowe
Tytuł :
Dramatic Response to Alectinib in a Critically Ill Elderly Patient with Lung Adenocarcinoma Due to Trousseau Syndrome and Disseminated Intravascular Coagulation.
Autorzy :
Hamada N; Department of Respiratory Medicine, Okayama City Hospital, Japan.
Tada Y; Department of Respiratory Medicine, Okayama City Hospital, Japan.
Hisamatsu K; Department of Respiratory Medicine, Okayama City Hospital, Japan.
Yamamoto Y; Department of Respiratory Medicine, Okayama City Hospital, Japan.
Yamano T; Department of Respiratory Medicine, Okayama City Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2022 Jan 15; Vol. 61 (2), pp. 229-232. Date of Electronic Publication: 2021 Jul 17.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/complications
Adenocarcinoma of Lung*/drug therapy
Disseminated Intravascular Coagulation*/complications
Disseminated Intravascular Coagulation*/drug therapy
Lung Neoplasms*/complications
Lung Neoplasms*/drug therapy
Aged ; Carbazoles ; Critical Illness ; Humans ; Piperidines
Czasopismo naukowe
Tytuł :
Relationship between F-FDG PET/CT Semi-Quantitative Parameters and International Association for the Study of Lung Cancer, American Thoracic Society/European Respiratory Society Classification in Lung Adenocarcinomas.
Autorzy :
Bu L; PET/CT/MRI and Molecular Imaging Center, Renmin Hospital of Wuhan University, Wuhan, China.
Tu N; PET/CT/MRI and Molecular Imaging Center, Renmin Hospital of Wuhan University, Wuhan, China.
Wang K; PET/CT/MRI and Molecular Imaging Center, Renmin Hospital of Wuhan University, Wuhan, China.
Zhou Y; PET/CT/MRI and Molecular Imaging Center, Renmin Hospital of Wuhan University, Wuhan, China.
Xie X; Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Han X; Department of Nuclear Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Lin H; Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Feng H; PET/CT/MRI and Molecular Imaging Center, Renmin Hospital of Wuhan University, Wuhan, China. .
Pokaż więcej
Źródło :
Korean journal of radiology [Korean J Radiol] 2022 Jan; Vol. 23 (1), pp. 112-123.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/genetics
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Adult ; Aged ; Aged, 80 and over ; Female ; Fluorodeoxyglucose F18 ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Positron Emission Tomography Computed Tomography ; Prognosis ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
A clinicopathological study of lung adenocarcinomas with pure ground-glass opacity > 3 cm on high-resolution computed tomography.
Autorzy :
Sun K; Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.
Xie H; Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.
Zhao J; Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.
Wang B; Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.
Bao X; Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.
Zhou F; Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China.
Zhang L; Department of Pathology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China. .
Li W; Department of Radiology, Shanghai Pulmonary Hospital, Tongji University School of Medicine, 507 Zheng Min Road, Shanghai, 200433, China. .
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2022 Jan; Vol. 32 (1), pp. 174-183. Date of Electronic Publication: 2021 Jun 16.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/diagnostic imaging
Lung Neoplasms*/diagnostic imaging
Humans ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local ; Retrospective Studies ; Tomography, X-Ray Computed
Czasopismo naukowe
Tytuł :
Rapidly Progressive Dysphagia and Weight Loss.
Autorzy :
Ewy MW; Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Kamboj AK; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
Johnson AM; Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: .
Pokaż więcej
Źródło :
Gastroenterology [Gastroenterology] 2022 Jan; Vol. 162 (1), pp. 56-58. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji :
Case Reports
MeSH Terms :
Deglutition*
Weight Loss*
Adenocarcinoma of Lung/*complications
Deglutition Disorders/*etiology
Esophageal Achalasia/*etiology
Lung Neoplasms/*complications
Paraneoplastic Syndromes/*etiology
Adenocarcinoma of Lung/diagnostic imaging ; Adenocarcinoma of Lung/therapy ; Chemotherapy, Adjuvant ; Deglutition Disorders/diagnosis ; Deglutition Disorders/physiopathology ; Disease Progression ; Esophageal Achalasia/diagnosis ; Esophageal Achalasia/physiopathology ; Esophageal Achalasia/surgery ; Female ; Humans ; Lung Neoplasms/diagnostic imaging ; Lung Neoplasms/therapy ; Middle Aged ; Paraneoplastic Syndromes/diagnosis ; Paraneoplastic Syndromes/physiopathology ; Paraneoplastic Syndromes/surgery ; Pneumonectomy ; Pyloromyotomy ; Time Factors ; Tomography, X-Ray Computed ; Treatment Outcome
Raport
Tytuł :
Hsa_circ_0005576 promotes osimertinib resistance through the miR-512-5p/IGF1R axis in lung adenocarcinoma cells.
Autorzy :
Liu S; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Jiang Z; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Xiao P; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Li X; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Chen Y; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Tang H; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Chai Y; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Liu Y; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Zhu Z; Department of Neurosurgery, Hunan Cancer Hospital, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
Xie Q; Department of Radiology, The Third Xiangya Hospital of Central South University, Changsha, China.
He W; Department of Pediatrics, The Third Xiangya Hospital of Central South University, Changsha, China.
Ma Y; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Jin L; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Feng W; Department of Cardiothoracic Surgery, The Third Xiangya Hospital of Central South University, Changsha, China.
Pokaż więcej
Źródło :
Cancer science [Cancer Sci] 2022 Jan; Vol. 113 (1), pp. 79-90. Date of Electronic Publication: 2021 Nov 15.
Typ publikacji :
Journal Article
MeSH Terms :
Drug Resistance, Neoplasm*
Adenocarcinoma of Lung/*pathology
Lung Neoplasms/*pathology
MicroRNAs/*genetics
RNA, Circular/*genetics
Receptor, IGF Type 1/*genetics
Acrylamides/pharmacology ; Acrylamides/therapeutic use ; Adenocarcinoma of Lung/drug therapy ; Adenocarcinoma of Lung/genetics ; Aniline Compounds/pharmacology ; Aniline Compounds/therapeutic use ; Animals ; Cell Line, Tumor ; Female ; Gene Expression Regulation, Neoplastic/drug effects ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Mice ; Neoplasm Transplantation ; Up-Regulation
Czasopismo naukowe
Tytuł :
Commentary: Is sublobar resection enough for ground-glass opacity-dominant lung adenocarcinoma?
Autorzy :
Zhang Y; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen H; Departments of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China; Institute of Thoracic Oncology, Shanghai Medical College, Fudan University, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: .
Pokaż więcej
Źródło :
The Journal of thoracic and cardiovascular surgery [J Thorac Cardiovasc Surg] 2022 Jan; Vol. 163 (1), pp. 303-304. Date of Electronic Publication: 2020 Oct 08.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/surgery
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/surgery
Humans ; Pneumonectomy
Opinia redakcyjna
Tytuł :
Circulating C-reactive protein increases lung cancer risk: Results from a prospective cohort of UK Biobank.
Autorzy :
Ji M; Department of Epidemiology, School of Public Health, Southeast University, Nanjing, China.; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Du L; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Ma Z; Department of Epidemiology, School of Public Health, Southeast University, Nanjing, China.; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Xie J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Huang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Wei X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Jiang X; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.
Xu J; Department of Thoracic Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Yin R; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Wang Y; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Dai J; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Jin G; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Xu L; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.
Zhu C; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
Hu Z; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Ma H; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Zhu M; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Thoracic Surgery, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.
Shen H; Department of Epidemiology, School of Public Health, Southeast University, Nanjing, China.; Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China.; Department of Cancer Prevention, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China.; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.; Research Units of Cohort Study on Cardiovascular Diseases and Cancers, Chinese Academy of Medical Sciences, Beijing, China.
Pokaż więcej
Źródło :
International journal of cancer [Int J Cancer] 2022 Jan 01; Vol. 150 (1), pp. 47-55. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung/*epidemiology
Biomarkers, Tumor/*blood
C-Reactive Protein/*analysis
Carcinoma, Non-Small-Cell Lung/*epidemiology
Carcinoma, Squamous Cell/*epidemiology
Small Cell Lung Carcinoma/*epidemiology
Adenocarcinoma of Lung/blood ; Adenocarcinoma of Lung/genetics ; Biological Specimen Banks ; Carcinoma, Non-Small-Cell Lung/blood ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Squamous Cell/blood ; Carcinoma, Squamous Cell/genetics ; Female ; Follow-Up Studies ; Humans ; Male ; Mendelian Randomization Analysis ; Middle Aged ; Polymorphism, Single Nucleotide ; Prognosis ; Prospective Studies ; Small Cell Lung Carcinoma/blood ; Small Cell Lung Carcinoma/genetics ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Heterogeneous distribution of PD-L1 expression in the IASLC/ATS/ERS classification of lung adenocarcinoma.
Autorzy :
Zhang D; Department of Pathology, The Third Affiliated Hospital of Soochow University, Juqian Road No.185, Changzhou, Jiangsu, 213003, People's Republic of China.
Gao X; Department of Pathology, The Third Affiliated Hospital of Soochow University, Juqian Road No.185, Changzhou, Jiangsu, 213003, People's Republic of China.
Yan Z; Department of Pathology, The Third Affiliated Hospital of Soochow University, Juqian Road No.185, Changzhou, Jiangsu, 213003, People's Republic of China.
He W; Department of Oncology, The Third Affiliated Hospital of Soochow University, Juqian Road No.185, Changzhou, Jiangsu, 213003, People's Republic of China. .
Li Q; Department of Pathology, The Third Affiliated Hospital of Soochow University, Juqian Road No.185, Changzhou, Jiangsu, 213003, People's Republic of China. .
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2022 Jan; Vol. 27 (1), pp. 105-111. Date of Electronic Publication: 2021 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma*/genetics
Adenocarcinoma*/pathology
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
B7-H1 Antigen/genetics ; Humans ; Neoplasm Staging ; Prognosis
Czasopismo naukowe
Tytuł :
Comparing survival and subsequent treatment of first-line tyrosine kinase inhibitors in patients of advanced lung adenocarcinoma with epidermal growth factor receptor mutation.
Autorzy :
Huang MY; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pharmacy, Linkou Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Hsieh KP; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Pharmacy, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Huang RY; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.
Hung JY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen LT; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Tsai MJ; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Internal Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Respiratory Therapy, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan. Electronic address: .
Yang YH; School of Pharmacy, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. Electronic address: .
Pokaż więcej
Źródło :
Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2022 Jan; Vol. 121 (1 Pt 1), pp. 170-180. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
ErbB Receptors/genetics ; Humans ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Prussian Blue/Calcium Peroxide Nanocomposites-Mediated Tumor Cell Iron Mineralization for Treatment of Experimental Lung Adenocarcinoma.
Autorzy :
Zhang K; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
Wu J; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
Zhao X; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
Qin J
Xue Y; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
Zheng W
Wang L
Wang H; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
Shen H
Niu T; Nuclear & Radiological Engineering and Medical Physics Programs, Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, United States.
Luo Y; Department of Biochemistry, Zhejiang University School of Medicine, Hangzhou 310058, China.
Tang R; Department of Chemistry, Zhejiang University, Hangzhou 310027, China.
Wang B; Institute of Translational Medicine, Zhejiang University, Hangzhou 310029, China.
Pokaż więcej
Źródło :
ACS nano [ACS Nano] 2021 Dec 28; Vol. 15 (12), pp. 19838-19852. Date of Electronic Publication: 2021 Dec 01.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung*/diagnostic imaging
Adenocarcinoma of Lung*/drug therapy
Lung Neoplasms*/diagnostic imaging
Lung Neoplasms*/drug therapy
Nanocomposites*
Cell Line, Tumor ; Ferrocyanides ; Humans ; Iron ; Peroxides ; Tumor Microenvironment
Czasopismo naukowe
Tytuł :
Pyrotinib in the treatment of advanced lung adenocarcinoma with HER2 exon 20 mutation: a case report and literature review.
Autorzy :
Luo Y; Department of Radiotherapy and Chemotherapy, The Affiliated People's Hospital, Ningbo University, Ningbo, China.
Yao B; Department of Radiotherapy and Chemotherapy, The Affiliated People's Hospital, Ningbo University, Ningbo, China.
Huang P; Department of Radiotherapy and Chemotherapy, The Affiliated People's Hospital, Ningbo University, Ningbo, China.
Zhao Y; Department of Radiotherapy and Chemotherapy, The Affiliated People's Hospital, Ningbo University, Ningbo, China.
Chen J; Department of Radiotherapy and Chemotherapy, The Affiliated People's Hospital, Ningbo University, Ningbo, China.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2021 Dec; Vol. 10 (12), pp. 12906-12910.
Typ publikacji :
Case Reports; Review
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Acrylamides ; Aged ; Aminoquinolines ; Exons/genetics ; Female ; Humans ; Mutation
Recenzja
Tytuł :
Case report: EGFR-mutant lung adenocarcinoma with the TP53 and RB1 mutations showed resistance to TKI therapy.
Autorzy :
Lu Y; Oncology Department, Nanhai People's Hospital, Foshan, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Li Z; Oncology Department, Nanhai People's Hospital, Foshan, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Zhu H; Department of Oncology, Second Affiliated Hospital of Guangxi Medical University, Nanning, China.
Zhao J; Shanghai OrigiMed Co., Ltd., Shanghai, China.
Xu M; Shanghai OrigiMed Co., Ltd., Shanghai, China.
Gu W; Oncology Department, Nanhai People's Hospital, Foshan, China; The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
Pokaż więcej
Źródło :
Annals of palliative medicine [Ann Palliat Med] 2021 Dec; Vol. 10 (12), pp. 12886-12893.
Typ publikacji :
Case Reports
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Carcinoma, Non-Small-Cell Lung*
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Drug Resistance, Neoplasm/genetics ; ErbB Receptors/genetics ; Humans ; Mutation ; Protein Kinase Inhibitors/therapeutic use ; Retinoblastoma Binding Proteins ; Tumor Suppressor Protein p53 ; Ubiquitin-Protein Ligases
Raport
Tytuł :
[Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Autorzy :
Li JL; Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China Beijing University of Chinese Medicine Beijing 100029, China.
Hou W; Guang'anmen Hospital, China Academy of Chinese Medical Sciences Beijing 100053, China.
Pokaż więcej
Źródło :
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica [Zhongguo Zhong Yao Za Zhi] 2021 Dec; Vol. 46 (23), pp. 6261-6270.
Typ publikacji :
Journal Article
MeSH Terms :
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Carcinoma, Non-Small-Cell Lung*
Drugs, Chinese Herbal*
Hedyotis*
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Humans ; Medicine, Chinese Traditional ; Molecular Docking Simulation ; Network Pharmacology
Czasopismo naukowe
Tytuł :
Development of a gene signature associated with iron metabolism in lung adenocarcinoma.
Autorzy :
Qin J; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Xu Z; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Deng K; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Qin F; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.; School of Information and Management, Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Wei J; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Yuan L; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Sun Y; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Zheng T; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Li S; Department of Thoracic and Cardiovascular Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region, P. R. China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 4556-4568.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/metabolism
Adenocarcinoma of Lung*/mortality
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/mortality
Iron/*metabolism
Biomarkers, Tumor/genetics ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; Transcriptome/genetics
Czasopismo naukowe
Tytuł :
Single-cell RNA sequencing reveals distinct tumor microenvironmental patterns in lung adenocarcinoma.
Autorzy :
Bischoff P; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. .; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany. .
Trinks A; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Obermayer B; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Pett JP; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Wiederspahn J; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.
Uhlitz F; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Liang X; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Lehmann A; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Jurmeister P; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Elsner A; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Dziodzio T; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Rückert JC; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Neudecker J; Department of Surgery, Campus Charité Mitte and Campus Virchow-Klinikum, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Falk C; Institute of Transplant Immunology, Hannover Medical School, Hannover, Germany.; TTU-IICH Hannover-Braunschweig Site, German Center for Infectious Diseases (DZIF), Braunschweig, Germany.
Beule D; Core Unit Bioinformatics (CUBI), Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
Sers C; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Morkel M; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Horst D; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Blüthgen N; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Berlin Institute of Health, Charité-Universitätsmedizin Berlin, Berlin, Germany.; IRI Life Sciences, Humboldt University of Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Klauschen F; Institute of Pathology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK) Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Pokaż więcej
Źródło :
Oncogene [Oncogene] 2021 Dec; Vol. 40 (50), pp. 6748-6758. Date of Electronic Publication: 2021 Oct 18.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Gene Expression Regulation, Neoplastic*
Transcriptome*
Tumor Microenvironment*
Adenocarcinoma of Lung/*pathology
Biomarkers, Tumor/*metabolism
Lung Neoplasms/*pathology
Single-Cell Analysis/*methods
Adenocarcinoma of Lung/genetics ; Adenocarcinoma of Lung/immunology ; Adenocarcinoma of Lung/metabolism ; Biomarkers, Tumor/genetics ; CD8-Positive T-Lymphocytes/immunology ; Gene Expression Profiling ; Humans ; Lung Neoplasms/genetics ; Lung Neoplasms/immunology ; Lung Neoplasms/metabolism ; Lymphocytes, Tumor-Infiltrating/immunology ; Prognosis ; Survival Rate
Czasopismo naukowe
Tytuł :
A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.
Autorzy :
Song J; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Sun Y; Department of Radiation Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Cao H; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, Nanjing Chest Hospital, The Affiliated Nanjing Brain hospital of Nanjing Medical University, and The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, China.
Liu Z; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, Nanjing Chest Hospital, The Affiliated Nanjing Brain hospital of Nanjing Medical University, and The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, China.
Xi L; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, Nanjing Chest Hospital, The Affiliated Nanjing Brain hospital of Nanjing Medical University, and The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, China.
Dong C; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, Nanjing Chest Hospital, The Affiliated Nanjing Brain hospital of Nanjing Medical University, and The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, China.
Yang R; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, Nanjing Chest Hospital, The Affiliated Nanjing Brain hospital of Nanjing Medical University, and The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, China.
Shi Y; Department of Thoracic Surgery, Nanjing Chest Hospital, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, The Affiliated Nanjing Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.; Department of Thoracic Surgery, Nanjing Chest Hospital, The Affiliated Nanjing Brain hospital of Nanjing Medical University, and The Pulmonary Nodule Diagnosis and Treatment Research Center of Nanjing Medical University, Nanjing, Jiangsu, China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 5932-5949.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung*/diagnosis
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/metabolism
Adenocarcinoma of Lung*/mortality
Lung Neoplasms*/diagnosis
Lung Neoplasms*/genetics
Lung Neoplasms*/metabolism
Lung Neoplasms*/mortality
Pyroptosis/*genetics
RNA, Long Noncoding/*genetics
Aged ; Cell Line, Tumor ; Computational Biology ; Databases, Genetic ; Female ; Humans ; Male ; Middle Aged ; Prognosis ; RNA, Long Noncoding/metabolism ; Transcriptome/genetics
Czasopismo naukowe
Tytuł :
Evaluation of tumor microenvironmental immune regulation and prognostic in lung adenocarcinoma from the perspective of purinergic receptor P2Y13.
Autorzy :
Wang J; Department of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.; The First Clinical Medical College of Lanzhou University, Lanzhou, PR China.
Shi W; Clinical Skills Center of Yantai Affiliated Hospital of Binzhou Medical College, Yantai, PR China.
Miao Y; The First Clinical Medical College of Lanzhou University, Lanzhou, PR China.
Gan J; The First Clinical Medical College of Lanzhou University, Lanzhou, PR China.
Guan Q; The First Clinical Medical College of Lanzhou University, Lanzhou, PR China.; Department of Oncology Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.
Ran J; Department of Radiation Oncology, The First Hospital of Lanzhou University, Lanzhou, Gansu, PR China.; The First Clinical Medical College of Lanzhou University, Lanzhou, PR China.
Pokaż więcej
Źródło :
Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 6286-6304.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/immunology
Adenocarcinoma of Lung*/mortality
Lung Neoplasms*/genetics
Lung Neoplasms*/immunology
Lung Neoplasms*/mortality
Receptors, Purinergic P2*/genetics
Receptors, Purinergic P2*/immunology
Tumor Microenvironment*/genetics
Tumor Microenvironment*/immunology
Aged ; Animals ; Female ; Humans ; Male ; Mice ; Mice, Inbred C57BL ; Middle Aged ; Prognosis ; Protein Interaction Maps/genetics ; Protein Interaction Maps/immunology ; Transcriptome/genetics ; Transcriptome/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies